Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenic Breast Cancer”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07355361
What this trial is testing

Huaier Granule and Proteinuria

Who this might be right for
ProteinuriaBreast Cancer Patients
Fudan University 120
Very early researchStudy completedNCT00727948
What this trial is testing

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Who this might be right for
Breast CancerAngiogenesis
University of Vermont 11
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Large-scale testing (Phase 3)Study completedNCT00524849
What this trial is testing

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Who this might be right for
Metastatic Breast CancerBone Metastases
Fudan University 60
Testing effectiveness (Phase 2)Ended earlyNCT00476827
What this trial is testing

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain

Who this might be right for
Breast Cancer
Duke University 16
Not applicableStudy completedNCT00393341
What this trial is testing

Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

Who this might be right for
Breast Cancer Stage IVBreast Cancer Stage IBreast Cancer Stage II
Indiana University School of Medicine 68
Testing effectiveness (Phase 2)Looking for participantsNCT06878625
What this trial is testing

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Who this might be right for
Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 138
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Testing effectiveness (Phase 2)Study completedNCT02839668
What this trial is testing

The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)

Who this might be right for
Breast Cancer
Iuliu Hatieganu University of Medicine and Pharmacy 120
Not applicableUnknownNCT01254591
What this trial is testing

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+2 more
University College London (UCL) Cancer Institute 500
Testing effectiveness (Phase 2)Study completedNCT00577122
What this trial is testing

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerRecurrent Breast Cancer+1 more
Indiana University 30
Not applicableStudy completedNCT00646555
What this trial is testing

Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)UnknownNCT00378638
What this trial is testing

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study

Who this might be right for
Breast Cancer
Chap, Linnea I., M.D. 30
Early research (Phase 1)Study completedNCT00322400
What this trial is testing

Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Who this might be right for
Locally Recurrent and Metastatic Breast Cancer
Amgen 46
Not applicableUnknownNCT01148407
What this trial is testing

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Who this might be right for
Cancer
University of Vermont 30
Testing effectiveness (Phase 2)Ended earlyNCT01067989
What this trial is testing

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Who this might be right for
ChemotherapyBreast Cancer, Metastatic
HaEmek Medical Center, Israel 22
Not applicableStudy completedNCT01943916
What this trial is testing

The PIONEER-01 Study of the Imagio Breast Imaging System

Who this might be right for
Breast Cancer
Seno Medical Instruments Inc. 2,105
Large-scale testing (Phase 3)UnknownNCT02865304
What this trial is testing

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Who this might be right for
AngiogenesisBreast Cancer
Fujian Cancer Hospital 80
Not applicableStudy completedNCT01341171
What this trial is testing

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Who this might be right for
Breast Cancer
University of Vermont 30
Testing effectiveness (Phase 2)Looking for participantsNCT06976944
What this trial is testing

Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

Who this might be right for
Recurrent Triple-Negative Breast Cancer
Yukinori Ozaki 44
Load More Results